Tandem Diabetes Care achieves record Q1 2025 sales with 22% growth, launches Control-IQ+ for type 2 diabetes, doubling its market potential.

Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

Millions of Medicaid beneficiaries have limited access to Type 2 diabetes medications that reduce the risk of cardiovascular disease, according to a study published April 22 in Annals of Internal ...

The first successful Achieve-1 study was done to evaluate the safety and efficacy of the drug in treating patients with type ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Type 2 diabetes requires constant management. First, it’s important to check your blood sugar regularly to make sure it’s not too high. Taking the right doses of medication is necessary to ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

Image credit: mbbirdy/Getty Images. A new study investigates the relationship between specific diabetes drugs and dementia. They used data from more than 92,000 people with type 2 diabetes.

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take ...

While conventional hypoglycemic agents are administered via insulin injections to control blood sugar, the oral diabetes medication SGLT2i reduces blood sugar by blocking the reabsorption of ...

The findings provide crucial insights into the potential for diabetes medications to influence long-term brain health. Dr Catriona Reddin, senior author, researcher at the University of Galway and ...